Difference between revisions 714612652 and 714615577 on enwiki

'''Zerona''' is a low-level laser device developed by Erchonia Corp. for non-invasive body slimming of the waist, hips, and thighs. It has been shown to disrupt [[adipocyte]], or fat cell, membranes causing the release of stored [[lipids]] and fatty material, in turn, promoting adipocyte collapse. The device was first introduced to the market in 2008 as an [[off-label use]] device for slimming, but later was cleared as a [[Medical device#Class II: General controls with special (contracted; show full)
Initial trials for Zerona began in late 1998 in Cali, Colombia, by Rodrigo Neira and his wife Clara Neira at the [[Universidad Nacional de Colombia]]. They first applied the device as an adjunct to [[liposuction]] to reduce pain and inflammation commonly experienced after the invasive surgical procedure. In hopes of achieving better pain reduction they began applying LLLT prior to aspiration and found that the subcutaneous fat appeared softer and easier to extract. Fascinated with this finding,{{cn
|date=April 2016}} the Neiras started performing histological investigations to determine why laser had its biological influence on fat tissue. Using [[scanning electron microscopy]] and [[transmission electron microscopy]], they observed the formation of transitory pores or openings in the protective membranes of adipocytes which enabled stored intracellular lipids to be released from enlarged fat cells. The term ''emulsification'' was applied to describe the laser-induced liberation of the stored lipi(contracted; show full)== References ==
{{reflist|2}}

==External links==
* [http://www.erchonia.com/ Erchonia Corp., Official Website]

[[Category:Laser medicine]]
[[Category:Management of obesity]]